The Central Drugs Standard Control Organisation (CDSCO) has published a list of drugs declared as Not of Standard Quality for April 2024. It has also published a list of drugs found to be spurious in April 2024. Both these lists were published on May 17, 2024.
Spurious Alert – April 2024
The spurious drug list specifies a total of 5 products/ drugs that were detected to be spurious in nature. Out of these the following 4 were found to be spurious in the National Capital Territory of Delhi:
- Instgra Tablets (Dolutegravir Tablets IP 50 mg)
- Telmisartan 40mg and Amlodipine 5mg Tablets I.P. (TelmaAM)
- Domperidone and Naproxen Sodium Tablets (Naxdom 500)
- Rifaximin Tablets (Rifagut 400)
Additionally in the state of Jharkhand Cefixime Trihydrate with Lactic Acid Bacillus Tablets LP. (Presef 200 LB Tablets) was found to be spurious. This same drug was also found to be Not of Standard Quality (NSQ).
Not of Standard Quality Alert – April 2024
The NSQ drug list specifies a total of 50 products/ drugs that were detected to be not of standard quality. Out of these 33 were reported from CDSCO/Central Laboratories and the remaining 17 were reported from state laboratories.
Out of the 33 NSQ drugs from CDSCO/Central Laboratories, 22 were reported by Central Drug Laboratory (CDL), Kolkata; 7 were reported by Regional Drugs Testing Laboratory (RDTL), Chandigarh; 3 were reported by RDTL, Guwahati and 1 was reported by Central Drugs Testing Laboratory (CDTL), Indore.
Additionally, in the state laboratories reported the following drugs as NSQ:
- State Drugs Testing Laboratory Srinagar (Jammu & Kashmir)
- Ceftriaxone Injection IP 250 mg (JKMSCL Hospital Supply) and
- Exudase DP
- State Food & Drugs Laboratory, Bambolim, Goa
- Rabeprazole Sodium Tablets IP20mg (RAB 20mg) and
- Rabeprazole Sodium Tablets IP (CYRA)
- State Drugs Testing Laboratory Thiruvananth apuram, Kerala
- Metronidazole Tablets IP 200 mg
- Ciprofloxacin Tablets IP 500 mg
- Bimatoprost Eye Drops 3 ml
- Frusemide Injection IP 20 mg Salbutamol Nebuliser Solution BP
- Warfarin sodium Tablet IP 5 mg
- Amloheart-AT [Amlodipine Besylate and Atenolol Tablets]
- Bupivacaine Hydrochloride in Dextrose Inj. USP 0.50% 4 ml Amp
- Mucoid-A [Acetyl Cysteine & Ambroxol HCL Tablets ]
- Sallaki Tablets and
- Panion Tablets
- MP State lab
- Paracetamo Paediatric Oral Suspension IP 125 mg/ml
- Paracetamo Paediatric Oral Suspension IP 250 mg/ml
Furthermore, spurious alert data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Uttar Pradesh for the Month of April, 2024. Similarly, NSQ alert data was not received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Karnataka & Uttar Pradesh for the Month of April, 2024.
The State Drugs Licensing Authorities of Mizoram, Tripura, Pondicherry have stated the Spurious and the NSQ data as “NIL” for the Month of April, 2024.
State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Haryana, Himachal Pradesh, Maharashtra, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Rajasthan, Sikkim, Tamil Nadu, Telangana, Uttarakhand, West Bengal, Andaman & Nicobar, Dadar and Nagar Haveli; Daman and Diu, Lakshadweep have not submitted any data in respect of the Spurious and NSQ Alert for the Month of April, 2024.
